Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,405 | -3,415 | -9,516 | -288 | -7,810 |
| Depreciation Amortization | 7,484 | 7,278 | 7,855 | 7,901 | 8,812 |
| Income taxes - deferred | 363 | 336 | -414 | -330 | -23 |
| Accounts receivable | 974 | 810 | 4,780 | -4,294 | 3,105 |
| Accounts payable and accrued liabilities | -1,785 | -523 | -1,399 | 2,454 | 1,491 |
| Other Working Capital | 65 | 4,600 | 2,716 | -10,190 | 4,106 |
| Other Operating Activity | 6,744 | 4,942 | -2,870 | 6,009 | -350 |
| Operating Cash Flow | $1,440 | $14,028 | $1,152 | $1,262 | $9,331 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,919 | N/A | N/A | N/A | N/A |
| PPE Investments | -2,644 | -1,276 | -1,590 | -1,195 | -1,152 |
| Purchase Sale Intangibles | -619 | -523 | N/A | -150 | -250 |
| Other Investing Activity | -619 | -523 | 0 | -150 | -250 |
| Investing Cash Flow | $-1,344 | $-1,799 | $-1,590 | $-1,345 | $-1,402 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,800 | 4,500 | 7,800 | 4,250 | 61,315 |
| Debt Repayment | -8,573 | -15,041 | -9,586 | -4,200 | -66,912 |
| Common Stock Issued | 380 | 930 | 577 | 3,314 | 669 |
| Other Financing Activity | -738 | -2,523 | -1,628 | -3,616 | -3,039 |
| Financing Cash Flow | $-131 | $-12,134 | $-2,837 | $-252 | $-7,967 |
| Exchange Rate Effect | -140 | -320 | -38 | -161 | 20 |
| Beginning Cash Position | 4,283 | 4,508 | 7,821 | 8,317 | 8,335 |
| End Cash Position | 4,108 | 4,283 | 4,508 | 7,821 | 8,317 |
| Net Cash Flow | $-175 | $-225 | $-3,313 | $-496 | $-18 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,440 | 14,028 | 1,152 | 1,262 | 9,331 |
| Capital Expenditure | -2,644 | -1,788 | -1,590 | -1,195 | -1,152 |
| Free Cash Flow | -1,204 | 12,240 | -438 | 67 | 8,179 |